[{"orgOrder":0,"company":"Morinaga Milk Industry Co., LTD","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"JAPAN","productType":"Probiotic","year":"2024","type":"Inapplicable","leadProduct":"Bifidobacterium Longum","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"Morinaga Milk Industry Co., LTD","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Morinaga Milk Industry Co., LTD \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Morinaga Milk Industry Co., LTD \/ Undisclosed"},{"orgOrder":0,"company":"University College Cork","sponsor":"Atlantia Food Clinical Trials | CREMO SA","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"IRELAND","productType":"Probiotic","year":"2019","type":"Inapplicable","leadProduct":"Bifidobacterium Longum","moa":"Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Undisclosed","graph3":"University College Cork","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University College Cork \/ Atlantia Food Clinical Trials | CREMO SA","highestDevelopmentStatusID":"1","companyTruncated":"University College Cork \/ Atlantia Food Clinical Trials | CREMO SA"},{"orgOrder":0,"company":"Nestle Health Sciences SA","sponsor":"McMaster University","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"SWITZERLAND","productType":"Probiotic","year":"2011","type":"Inapplicable","leadProduct":"Bifidobacterium Longum","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Phase I\/ Phase II","graph3":"Nestle Health Sciences SA","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Powder","sponsorNew":"Nestle Health Sciences SA \/ McMaster University","highestDevelopmentStatusID":"7","companyTruncated":"Nestle Health Sciences SA \/ McMaster University"},{"orgOrder":0,"company":"Nestle Health Sciences SA","sponsor":"Syneos Health | Medidata Solutions | McMaster University | CaligorRx, Inc.","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"SWITZERLAND","productType":"Probiotic","year":"2021","type":"Inapplicable","leadProduct":"Bifidobacterium Longum","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Phase I\/ Phase II","graph3":"Nestle Health Sciences SA","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Powder","sponsorNew":"Nestle Health Sciences SA \/ Syneos Health | Medidata Solutions | McMaster University | CaligorRx, Inc.","highestDevelopmentStatusID":"7","companyTruncated":"Nestle Health Sciences SA \/ Syneos Health | Medidata Solutions | McMaster University | CaligorRx, Inc."},{"orgOrder":0,"company":"University of Social Sciences and Humanities, Warsaw","sponsor":"Sanprobi | National Science Centre, Poland","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"POLAND","productType":"Probiotic","year":"2025","type":"Inapplicable","leadProduct":"Bifidobacterium Longum","moa":"Undisclosed","graph1":"Neurology","graph2":"Undisclosed","graph3":"University of Social Sciences and Humanities, Warsaw","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"University of Social Sciences and Humanities, Warsaw \/ Sanprobi | National Science Centre, Poland","highestDevelopmentStatusID":"1","companyTruncated":"University of Social Sciences and Humanities, Warsaw \/ Sanprobi | National Science Centre, Poland"}]

Find Clinical Drug Pipeline Developments & Deals for Bifidobacterium Longum

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          University of Social Sciences and Humanities, Warsaw

                          Country arrow
                          AIChE Annual Meeting
                          Not Confirmed

                          University of Social Sciences and Humanities, Warsaw

                          Country arrow
                          AIChE Annual Meeting
                          Not Confirmed

                          Details : Bifidobacterium Longum is a Probiotic drug candidate, which is currently being evaluated in Undisclosed clinical studies for the treatment of Cognitive Dysfunction.

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          September 10, 2025

                          Lead Product(s) : Bifidobacterium Longum

                          Therapeutic Area : Neurology

                          Highest Development Status : Undisclosed

                          Sponsor : Sanprobi | National Science Centre, Poland

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          Morinaga Milk Industry Co., LTD

                          Country arrow
                          AIChE Annual Meeting
                          Not Confirmed

                          Morinaga Milk Industry Co., LTD

                          Country arrow
                          AIChE Annual Meeting
                          Not Confirmed

                          Details : B. Longum is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Constipation.

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          November 13, 2024

                          Lead Product(s) : Bifidobacterium Longum

                          Therapeutic Area : Gastroenterology

                          Highest Development Status : Undisclosed

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          AIChE Annual Meeting
                          Not Confirmed
                          AIChE Annual Meeting
                          Not Confirmed

                          Details : Bifidobacterium Longum is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Irritable Bowel Syndrome.

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          September 23, 2021

                          Lead Product(s) : Bifidobacterium Longum

                          Therapeutic Area : Gastroenterology

                          Highest Development Status : Undisclosed

                          Sponsor : Syneos Health | Medidata Solutions | McMaster University | CaligorRx, Inc.

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          University College Cork

                          Country arrow
                          AIChE Annual Meeting
                          Not Confirmed

                          University College Cork

                          Country arrow
                          AIChE Annual Meeting
                          Not Confirmed

                          Details : Bifidobacterium Longum is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Obesity.

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          August 01, 2019

                          Lead Product(s) : Bifidobacterium Longum

                          Therapeutic Area : Nutrition and Weight Loss

                          Highest Development Status : Undisclosed

                          Sponsor : Atlantia Food Clinical Trials | CREMO SA

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          AIChE Annual Meeting
                          Not Confirmed
                          AIChE Annual Meeting
                          Not Confirmed

                          Details : Bifidobacterium Longum is a Probiotic drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Irritable Bowel Syndrome.

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          January 13, 2011

                          Lead Product(s) : Bifidobacterium Longum

                          Therapeutic Area : Gastroenterology

                          Highest Development Status : Phase I/ Phase II

                          Sponsor : McMaster University

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank